--- title: Trialbee Inks Deal with Acclinate in Push for Trial Diversity description: Trialbee, a patient enrollment company, inked a partnership deal with Acclinate in a push to accelerate wider patient diversity in clinical trials. image: https://news.acclinate.com/hubfs/Diversity.jpg --- [![Acclinate Logo](https://news.acclinate.com/hs-fs/hubfs/Acclinate-logo.png?width=2000&height=497&name=Acclinate-logo.png "Acclinate Logo")](https://www.acclinate.com/) - Products - [NOWINCLUDED](https://www.acclinate.com/products/nowincluded-the-community) - [eDICT](https://www.acclinate.com/products/e-dict) - Solutions - [Pharmaceutical Companies](https://www.acclinate.com/solutions/for-pharmaceutical-companies) - [Contract Research Organizations](https://www.acclinate.com/solutions/for-cros) - [Partners](https://www.acclinate.com/solutions/community-partners) - Company - [About Us](https://www.acclinate.com/about) - [Careers](https://www.acclinate.com/careers) - [News](https://news.acclinate.com) - Resources - [Resource Library](https://www.acclinate.com/resources) - [Blog](https://blog.acclinate.com) - [Press Kit](https://www.acclinate.com/press-kit) - [Events](https://www.acclinate.com/events) - [Glossary](https://www.acclinate.com/glossary) - [FAQ](https://www.acclinate.com/faq) - [Talk to Our Team](https://info.acclinate.com/get-in-touch) [![Talk to Our Team](https://no-cache.hubspot.com/cta/default/19943632/2e1c34dc-aaa1-43b8-b5f4-469b0db4e302.png)](https://cta-redirect.hubspot.com/cta/redirect/19943632/2e1c34dc-aaa1-43b8-b5f4-469b0db4e302) [![Acclinate Logo](https://news.acclinate.com/hs-fs/hubfs/Acclinate_Logo.png?width=500&height=149&name=Acclinate_Logo.png "Acclinate Logo")](https://www.acclinate.com/) - Products - [**NOWINCLUDED**Acclinate’s B2C community platform ](https://www.acclinate.com/products/nowincluded-the-community) - [**e-DICT**Acclinate’s patented AI-powered technology ](https://www.acclinate.com/products/e-dict) - Solutions - [**Pharmaceutical Companies**Community-driven recruitment and real-world insights to support diverse, compliant clinical trials. ](https://www.acclinate.com/solutions/for-pharmaceutical-companies) - [**Contract Research Organization (CRO)**Scalable patient engagement and recruitment solutions that reduce risk and improve enrollment timelines. ](https://www.acclinate.com/solutions/for-cros) - [**Partners**Trusted partnerships that connect research opportunities with the communities they aim to serve. ](https://www.acclinate.com/solutions/community-partners) - Company - [**About us**We help clinical research teams reach diverse communities, build trust, and improve trial participation. ](https://www.acclinate.com/about) - [**Careers**Join a mission-driven team advancing inclusive clinical research and community-powered health innovation. ](https://www.acclinate.com/careers) - Resources - [**Resources Hub** ](https://www.acclinate.com/resources) - [**Glossary** ](https://www.acclinate.com/glossary) - [**Press Kit** ](https://www.acclinate.com/press-kit) - [**Events** ](https://www.acclinate.com/events) - [**Blog** ](https://blog.acclinate.com/) - [**News** ](https://news.acclinate.com/) - [![](https://cdn.prod.website-files.com/695fbca039298e2117988a78/69e7b588548c7ad7bd8ab0bc_9dd915489696393dc63d7785ee2e52c7_Question%20mark%20image.png) **FAQs** ](https://www.acclinate.com/faq) - [ Contact Us ](https://www.acclinate.com/contact-us)   ## Community Engagement Stay updated on our latest company milestones, research publications, and the community engagement events that are continuously building authentic trust nationwide. [![Get the Press Kit](https://no-cache.hubspot.com/cta/default/19943632/16a8815b-a5bf-4ea5-ad35-b68efdee0793.png)](https://cta-redirect.hubspot.com/cta/redirect/19943632/16a8815b-a5bf-4ea5-ad35-b68efdee0793) Topics - [All](https://blog.acclinate.com/news) - [Acclinate ](https://news.acclinate.com/tag/acclinate) - [Awards ](https://news.acclinate.com/tag/awards) - [Community ](https://news.acclinate.com/tag/community) - [Diversity in Clinical Trials ](https://news.acclinate.com/tag/diversity-in-clinical-trials) - [Partnerships ](https://news.acclinate.com/tag/partnerships) - [Acclinate](https://news.acclinate.com/topic/acclinate) - [Partnerships](https://news.acclinate.com/topic/partnerships) # Trialbee Inks Deal with Acclinate in Push for Trial Diversity By Joseph Keenan December 14, 2022 ![Trialbee Inks Deal with Acclinate in Push for Trial Diversity](https://news.acclinate.com/hubfs/Diversity.jpg) Clinical Trial Diversity: What Does It Really Mean? Clinical trials are critical for evaluating the safety and effectiveness of medical devices and pharmaceutical products. The results of trials guide t... Read More https://www.fiercebiotech.com/cro/trialbee-inks-deal-acclimate-push-trial-diversity ![ Joseph Keenan](https://news.acclinate.com/hubfs/Acclinate/avatar-1577909_1280.webp) **Share this Article:** [**](https://www.facebook.com/sharer/sharer.php?u=https://news.acclinate.com/trialbee-inks-deal-with-acclinate-in-push-for-trial-diversity) [**](https://twitter.com/home?status=https://news.acclinate.com/trialbee-inks-deal-with-acclinate-in-push-for-trial-diversity) [** ](https://www.linkedin.com/shareArticle?mini=true&url=https://news.acclinate.com/trialbee-inks-deal-with-acclinate-in-push-for-trial-diversity&title=Trialbee%20Inks%20Deal%20with%20Acclinate%20in%20Push%20for%20Trial%20Diversity) Media: Find useful resources, including mission, fast facts, media downloads and more. [Get the Press Kit ](https://www.acclinate.com/press-kit) Interested in talking with Acclinate? [ Get in Touch ](https://cta-service-cms2.hubspot.com/web-interactives/public/v1/track/redirect?encryptedPayload=AVxigLIc6osXmKBv%2F%2FrWjVS5gpUHDx5BOvMnmTdh5N3JPqohgv4ro6XOk%2FRcpot8FI%2BG08%2B5aJ5MAt3kXAjzJ1eIgpjMdTxwe3P2DKSxLBnF9IvQvSweIh3OFR2Gpe5HC4YsFvSWe8MHjegsnfFJPvRobuSvbznUJ1nlWHHQAg0Z%2FuUUg%2FKMrv4AY6%2BLav8%3D&webInteractiveContentId=182419560361&portalId=19943632) Trialbee, a patient enrollment company, inked a [partnership deal](https://www.businesswire.com/news/home/20221213005211/en/Trialbee-and-Acclinate-Partner-to-Enhance-Equitable-Clinical-Trial-Participation) with Acclinate in a push to accelerate wider patient diversity in clinical trials. Under the partnership, Sweden-based Trialbee will get access to Acclinate’s NOWINCLUDED offering that engages diverse populations on health-related issues, the company said in a Dec. 13 press release. Founded in 2020, Birmingham, Alabama-based Acclinate is a digital health company focused on diversifying clinical trials. Its e-DICT platform assigns a proprietary Participant Probability Index score to assess community members’ willingness to participate in clinical research. Then, Trialbee’s Honey Omnichannel can refer interested participants to research sites. “Acclinate’s approach with NOWINCLUDED is innovative and focuses on overcoming well-documented issues around trust within communities of color,” Matt Walz, Trialbee’s chief executive, said in the release. “When combined with the power of our Honey platform, we’re much better positioned to achieve more equitable clinical research.” The two companies said lupus was chosen as the pilot indication for the collaboration. Trialbee launched Honey Omnichannel in late November saying the inflammatory disease would be an initial focus due to its complexity and unique patient populations. Lupus disproportionately affects women who identify as African American, Hispanic, Asian and Native American. [https://www.fiercebiotech.com/cro/trialbee-inks-deal-acclimate-push-trial-diversity](https://www.fiercebiotech.com/cro/trialbee-inks-deal-acclimate-push-trial-diversity) [![Acclinate, HCN Global Partner to Expand Hispanic & Latino Clinical Research Access](https://news.acclinate.com/hubfs/acclinate-hcn-global_(1).webp) December 14, 2022 ## Acclinate, HCN Global Partner to Expand Hispanic & Latino Clinical Research Access Read More ](https://news.acclinate.com/hispanic-clinical-research-access-acclinate-hcn-global) [![International Clinical Trials Day Renews Focus on Representation in Medical Research](https://news.acclinate.com/hubfs/acclinate-img.webp) December 14, 2022 ## International Clinical Trials Day Renews Focus on Representation in Medical Research Read More ](https://www.prlog.org/13147128-international-clinical-trials-day-renews-focus-on-representation-in-medical-research.html) [![Acclinate Releases 2025 Annual Impact Report Highlighting Community-Led Progress in Health Equity](https://news.acclinate.com/hubfs/acclinate-award.jpg) December 14, 2022 ## Acclinate Releases 2025 Annual Impact Report Highlighting Community-Led Progress in Health Equity Read More ](https://www.birminghamtimes.com/2023/08/first-ever-black-maternal-health-expo-coming-to-birmingham/) ![Woman wearing Acclinate Shirt](https://news.acclinate.com/hs-fs/hubfs/layer1_image.webp?width=1600&height=1068&name=layer1_image.webp) ![Medical Research Software e-DICT](https://news.acclinate.com/hs-fs/hubfs/layer2_image.webp?width=885&height=885&name=layer2_image.webp) ![layer2.2_image](https://news.acclinate.com/hs-fs/hubfs/layer2.2_image.webp?width=1505&height=1197&name=layer2.2_image.webp) ![layer3_image](https://news.acclinate.com/hs-fs/hubfs/layer3_image.webp?width=1600&height=1067&name=layer3_image.webp) ## Ready to Measure Your True Impact? Partner with Acclinate to turn mission into measurable, data-driven action. [ Get Started ](https://www.acclinate.com/contact-us) [![Acclinate Logo Reversed](https://news.acclinate.com/hs-fs/hubfs/footer_logo.png?width=1600&height=398&name=footer_logo.png "Acclinate Logo Reversed")](https://www.acclinate.com/) - Products - [NOWINCLUDED](https://www.acclinate.com/products/nowincluded-the-community) - [e-DICT](https://www.acclinate.com/products/e-dict) - Solutions - [Pharmaceutical Companies](https://www.acclinate.com/solutions/for-pharmaceutical-companies) - [CROs](https://www.acclinate.com/solutions/for-cros) - [Community Partners](https://www.acclinate.com/solutions/community-partners) - Resources - [Resources Hub](https://www.acclinate.com/resources) - [Glossary](https://www.acclinate.com/glossary) - [Press Kit](https://www.acclinate.com/press-kit) - [Events](https://www.acclinate.com/events) - [News](https://news.acclinate.com/) - [Blog](https://blog.acclinate.com/) - [FAQs](https://www.acclinate.com/faq) - Company - [About us](https://www.acclinate.com/about) - [Careers](https://www.acclinate.com/careers) - [Contact Us](https://www.acclinate.com/contact-us) - Follow Us - [** Linkedin](https://www.linkedin.com/company/acclinateinc/) - [Privacy Policy](https://www.acclinate.com/privacy) - [Terms of Service](https://www.acclinate.com/terms-of-use-acclinate) ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : { "@type" : "Person", "name" : "Joseph Keenan", "url" : "https://news.acclinate.com/author/joseph-keenan" }, "dateModified" : "2024-04-15T20:29:53.584Z", "datePublished" : "2022-12-14T06:54:00.000Z", "headline" : "Trialbee Inks Deal with Acclinate in Push for Trial Diversity", "image" : [ "https://news.acclinate.com/hubfs/Diversity.jpg" ], "mainEntityOfPage" : { "@id" : "https://news.acclinate.com/trialbee-inks-deal-with-acclinate-in-push-for-trial-diversity", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://news.acclinate.com/hubfs/Acclinate-logo%20(2).png" }, "name" : "Acclinate" } } ```